These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37503416)

  • 21. Retracted: CT Imaging Characteristics and Influence Factors of Renal Dialysis-Associated Peritoneal Injury.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9761426. PubMed ID: 37860494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862864. PubMed ID: 37476775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study.
    Mima A; Horii Y
    In Vivo; 2022; 36(4):1785-1789. PubMed ID: 35738640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Renal Anemia with Roxadustat: Advantages and Achievement.
    Li ZL; Tu Y; Liu BC
    Kidney Dis (Basel); 2020 Mar; 6(2):65-73. PubMed ID: 32309288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9817378. PubMed ID: 37621517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: Immunomodulatory Effect of
    Engineering JOH
    J Healthc Eng; 2023; 2023():9852810. PubMed ID: 36636669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta-analysis.
    Liu J; Zhang A; Hayden JC; Bhagavathula AS; Alshehhi F; Rinaldi G; Kontogiannis V; Rahmani J
    Pharmacol Res; 2020 May; 155():104747. PubMed ID: 32171893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis.
    Zheng L; Tian J; Liu D; Zhao Y; Fang X; Zhang Y; Liu Y
    Br J Clin Pharmacol; 2022 Mar; 88(3):919-932. PubMed ID: 34428860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
    Provenzano R; Besarab A; Wright S; Dua S; Zeig S; Nguyen P; Poole L; Saikali KG; Saha G; Hemmerich S; Szczech L; Yu KH; Neff TB
    Am J Kidney Dis; 2016 Jun; 67(6):912-24. PubMed ID: 26846333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retracted: Artificial Intelligence-Based Feature Analysis of Ultrasound Images of Liver Fibrosis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9897287. PubMed ID: 37859656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: Effect of Percutaneous Nephrolithotomy Combined with Needle Nephrolithotomy on Renal Function and Complication Rate in Patients with Complex Renal Calculi.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9821568. PubMed ID: 37388015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Mir-192-5p Alleviated Fibrosis and Inflammatory Responses of Tendon Cells by Targeting NFAT5.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9786183. PubMed ID: 37811293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roxadustat attenuates experimental pulmonary fibrosis in vitro and in vivo.
    Huang H; Wang X; Zhang X; Wang H; Jiang W
    Toxicol Lett; 2020 Oct; 331():112-121. PubMed ID: 32534005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9897437. PubMed ID: 37810553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: PASS-Predicted Hepatoprotective Activity of
    The Scientific World Journal
    ScientificWorldJournal; 2018; 2018():7465402. PubMed ID: 30158841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted: Renoprotective Effect of Intraoperative Dexmedetomidine in Renal Transplantation.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9841563. PubMed ID: 37811255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retracted: Analysis of Clinical Manifestations, Imaging Features, and Gene Mutation Characteristics of 6 Children with Cystic Fibrosis in China.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9758012. PubMed ID: 37387828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: PM2.5 Exposure Induces Lung Injury and Fibrosis by Regulating Ferroptosis via TGF-
    Markers D
    Dis Markers; 2023; 2023():9879138. PubMed ID: 37538088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction.
    Open Biomed Eng J; 2018; 12():91. PubMed ID: 37915339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.